ReviewJournal of clinical medicine2025
Controversies in Cavernous Malformation Management: A Comprehensive Review of Current Literature.
Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Leukocytosis at Presentation Is an Independent Predictor for Hemorrhage in Cerebral Cavernoma.Diagnostics (Basel, Switzerland) · 2026Article
- Visual Epilepsy Mimicking Migraine Aura Leading to Delayed Diagnosis of an Occipital Cavernoma: A Case Report.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial cavernous malformations (CMs) are angiographically occult, slow-flow vascular lesions composed of dilated, mulberry-like capillary clusters lacking intervening brain parenchyma. CMs typically have a low annual hemorrhage risk and are often discovered incidentally. Most patients are asymptomatic or exhibit mild neurological symptoms at the time of diagnosis. Despite decades of investigation, the optimal management of CMs remains controversial. Key clinical dilemmas include identifying which lesions warrant active treatment and when, selecting the best therapeutic approach based on patient age and lesion location (eloquent vs. non-eloquent areas), and determining how to address the hemosiderin rim often found surrounding the malformation. Additional questions involve the role of radiosurgery and appropriate management strategies during pregnancy. This review critically evaluates current literature concerning the natural history and treatment strategies for CMs, emphasizing evidence-based approaches to these unresolved issues. By summarizing and interpreting recent findings, we aim to provide a concise yet comprehensive overview to support clinicians in tailoring patient-specific management plans for this complex neurovascular pathology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.